Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Assets
Cash and cash equivalents	$ 253,637	$ 319,589
Investment securities, available-for-sale	508,359	436,404
Accounts receivable, net	107,505	98,739
Interest and other receivables	12,181	5,956
Inventory	26,124	21,949
Prepaid expenses	52,747	55,681
Total current assets	960,553	938,318
Property and equipment, net	3,547	4,215
Operating lease right-of-use assets	50,991	46,571
Intangible assets, net	114,338	119,782
Restricted cash	9,471	8,770
Long-term inventory	84,402	69,741
Other assets	2,253	359
Total assets	1,225,555	1,187,756
Liabilities and stockholders’ equity
Accounts payable	20,097	16,192
Accrued liabilities	309,927	378,678
Total current liabilities	330,024	394,870
Operating lease liabilities	44,601	42,037
Other long-term liabilities	28,548	18,056
Total liabilities	403,173	454,963
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at June 30, 2025 and December 31, 2024; no shares issued and outstanding at June 30, 2025 and December 31, 2024	0	0
Common stock, $0.0001 par value; 225,000,000 shares authorized at June 30, 2025 and December 31, 2024; 168,607,881 shares and 166,708,856 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively	16	16
Additional paid-in capital	2,980,693	2,936,871
Accumulated deficit	(2,158,733)	(2,204,386)
Accumulated other comprehensive income	406	292
Total stockholders’ equity	822,382	732,793
Total liabilities and stockholders’ equity	$ 1,225,555	$ 1,187,756